Selective inhibition of cytokine-induced lysozyme activity by tetanus toxin in the GG2EE macrophage cell line.
This study was designed to evaluate the effects of tetanus toxin (TT) on lysozyme (LZM) activity by the GG2EE macrophage cell line. GG2EE cells spontaneously produced low amounts of LZM, which were mostly secreted into the culture medium. Upon treatment with various cytokines, GG2EE cells exhibited altered LZM activity. In particular, exposure of GG2EE cells to alpha/beta interferon (IFN-alpha/beta) reduced LZM activity, as opposed to treatment with gamma interferon (IFN-gamma) or colony-stimulating factor 1, which potentiated LZM activity. Spontaneous LZM activity of GG2EE cells was not susceptible to TT action; in contrast, when IFN-gamma- or colony-stimulating factor 1-susceptible cells were treated with TT, a significant reduction on LZM activity was observed. The TT inhibitory effect was dose dependent and manifested only after a 6-h incubation of GG2EE cells with TT. Treatment of GG2EE cells with heat-inactivated TT as well as Ibc- and B-IIb-TT-derived fragments was found to be ineffective, while pretreatment with B-IIb- but not with Ibc-TT-derived fragment abrogated the TT effect. Overall, these data indicate the existence of a specific TT-GG2EE cell interaction, leading to selective inhibition of cytokine-induced LZM activity.
Pitzurra
L
L
Department of Experimental Medicine and Biochemical Sciences, University of Perugia, Italy.
Marconi
P
P
Bistoni
F
F
Blasi
E
E
D000818:Animals; D001667:Binding, Competitive; D001685:Biological Factors / Q000494:pharmacology*; D002460:Cell Line; D003115:Colony-Stimulating Factors / Q000494:pharmacology; D016207:Cytokines; D007370:Interferon Type I / Q000494:pharmacology; D007371:Interferon-gamma / Q000494:pharmacology; D007700:Kinetics; D008264:Macrophages / Q000201:enzymology*; D051379:Mice; D008970:Molecular Weight; D009113:Muramidase / Q000037:antagonists & inhibitors*; D010446:Peptide Fragments / Q000494:pharmacology; D013744:Tetanus Toxin / Q000037:antagonists & inhibitors / Q000494:pharmacology*
D001685:Biological Factors; D003115:Colony-Stimulating Factors; D016207:Cytokines; D007370:Interferon Type I; D010446:Peptide Fragments; D013744:Tetanus Toxin; D007371:Interferon-gamma; D009113:Muramidase